These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11859739)

  • 41. Colorectal cancer: chemotherapy treatment overview.
    Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capecitabine as third line therapy in patients with advanced colorectal cancer.
    Gubanski M; Naucler G; Almerud A; Lideståhl A; Lind PA
    Acta Oncol; 2005; 44(3):236-9. PubMed ID: 16076695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New drugs in the treatment of colorectal carcinoma.
    Punt CJ
    Cancer; 1998 Aug; 83(4):679-89. PubMed ID: 9708931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.
    Maung K; Lee D; DeGrendele HC; Schilsky R; Chu E; Jain VK; Copur S
    Clin Colorectal Cancer; 2002 Nov; 2(3):140-5. PubMed ID: 12482329
    [No Abstract]   [Full Text] [Related]  

  • 46. Review article: colorectal cancer chemotherapy.
    Gill S; Thomas RR; Goldberg RM
    Aliment Pharmacol Ther; 2003 Oct; 18(7):683-92. PubMed ID: 14510741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Capecitabine-based chemotherapy for metastatic colorectal cancer.
    Ling W; Fan J; Ma Y; Ma Y; Wang H
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):927-38. PubMed ID: 20936301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant therapy for stage II and III colorectal cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S37-40. PubMed ID: 17449351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
    Tsavaris N; Kosmas C; Vadiaka M; Koufos C
    BMC Cancer; 2002; 2():2. PubMed ID: 11860608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
    Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colon cancer: new drug options improve on 5-FU.
    McCann J
    J Natl Cancer Inst; 1998 Jul; 90(13):963-5. PubMed ID: 9665142
    [No Abstract]   [Full Text] [Related]  

  • 52. New chemotherapeutic strategies in colorectal cancer.
    Moehler M; Teufel A; Galle PR
    Recent Results Cancer Res; 2005; 165():250-9. PubMed ID: 15865041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M; Hummel S; Bansback N; Orr B; Seymour M
    Health Technol Assess; 2001; 5(25):1-128. PubMed ID: 11990245
    [No Abstract]   [Full Text] [Related]  

  • 54. [Principles of postoperative therapy in rectal carcinoma].
    Folprecht G; Köhne CH
    Chirurg; 2004 Jan; 75(1):32-7. PubMed ID: 14740125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
    Saltz LB; Douillard JY; Pirotta N; Alakl M; Gruia G; Awad L; Elfring GL; Locker PK; Miller LL
    Oncologist; 2001; 6(1):81-91. PubMed ID: 11161231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
    [No Abstract]   [Full Text] [Related]  

  • 58. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.
    Ychou M; Viret F; Kramar A; Desseigne F; Mitry E; Guimbaud R; Delpero JR; Rivoire M; Quénet F; Portier G; Nordlinger B
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):195-201. PubMed ID: 17901955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current approaches to first-line treatment of advanced colorectal cancer.
    Goldberg RM
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S9-15. PubMed ID: 15212700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
    Folprecht G; Hamann S; Schütte K; Trarbach T; Stoehlmacher-Williams J; Ehninger G
    BMC Cancer; 2014 Jul; 14():521. PubMed ID: 25038824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.